Hepatitis C News and Research

Latest Hepatitis C News and Research

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Roche's new cobas TaqScreen MPX viral discriminatory test, v2.0 now available in Europe

Roche's new cobas TaqScreen MPX viral discriminatory test, v2.0 now available in Europe

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Research roundup: Closing E.R.S; Predicting future health costs; Providing rural residents with specialized care

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C

Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Abbott RealTime PCR assay for measuring HCV viral load receives FDA marketing approval

Haiti presents plan to immunize 90 percent of newborns

Haiti presents plan to immunize 90 percent of newborns

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Benitec raises AU$8 million for gene silencing therapeutics

Benitec raises AU$8 million for gene silencing therapeutics

FDA nod for hepatitis C drug

FDA nod for hepatitis C drug

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference

The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

Merck receives FDA approval for Victrelis to treat chronic hepatitis C

Merck receives FDA approval for Victrelis to treat chronic hepatitis C

MRSA superbug detected in bed bugs and supermarket meats: Report

MRSA superbug detected in bed bugs and supermarket meats: Report

Supreme Court of Canada opens hearings on safe drug injection facility

Supreme Court of Canada opens hearings on safe drug injection facility

TFAH applauds HHS for new strategic approach to prevent viral hepatitis

TFAH applauds HHS for new strategic approach to prevent viral hepatitis

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

China Pharma first quarter revenue increases 20% to $18.1 million

China Pharma first quarter revenue increases 20% to $18.1 million

Majority of urban NYC women with hepatitis B do not receive education, subsequent care

Majority of urban NYC women with hepatitis B do not receive education, subsequent care

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.